Low dosage of interferon to enhance vaccine efficiency

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435811, A61K 4502

Patent

active

048205141

ABSTRACT:
A biologically active interferon can be administered to an animal in conjunction with the administration of a vaccine to improve the vaccine efficiency and allow the use of a smaller vaccination dose. This procedure will cause a less severe vaccine infection in the animal than if no interferon was administered.

REFERENCES:
patent: 3906092 (1975-09-01), Hilleman et al.
patent: 4053582 (1977-10-01), Stickl
patent: 4273703 (1981-06-01), Osther et al.
patent: 4322404 (1982-03-01), Gaure et al.
patent: 4429045 (1984-01-01), Bass et al.
patent: 4460574 (1984-07-01), Yabrov
patent: 4462985 (1984-07-01), Cummins, Jr.
patent: 4497795 (1985-05-01), Cummins
patent: 4675184 (1987-06-01), Hasegawa et al.
Epstein, L., Interferons and Their Actions, CRC Press, Inc., Boca Raton, Florida, Stewart II et al. editors, pp. 102-104, 1977.
Sonnenfeld et al., Cellular Immunology, vol. 40, pp. 285-293, 1978.
Rodder, H., Thumann, D., Thumann, E., Tierarztliche Umschau, vol. 34, No. 10, 1979, pp. 720-724 (summary).
Toneva, V., Bulletin de l'Office International des Epizooties, vol. 88, 1977, pp. 631-637 (Summary).
"In Vivo and Clinical Studies", Norman B. Finter & Robert K. Oldham, eds., Interferon, vol. 4, 1985, pp. 137, 148, 173, 218, 226, 284, 285, 330.
Chemical Abstracts, vol. 67, 1967, p. 7536 [80070u], Litvinov, A. N.
"Time and Dosage Dependence of Immunoenhancement by Murine Type II Interferon Preparations", Cellular Immunology, 40, 1978, pp. 285-293.
"Antiviral Effect of Bacterially Produced Human Interferon (Hu-IFNa.sub.2) Against Experimental Vaccinia Infection in Calves", Journal of Interferon Research, 5:129-136, 1985, Werenne, J., Broecke, C. V., Schwers, A., Goossens, A., Bugyaki, L., et al.
"Effect of Human Leukocyte A Interferon on Prevention of Infectious Bovine Rhinotracheitis Virus Infection of Cattle", Roney, C. S. et al., Am J. Vet. Res., vol. 46, No. 6, Jun. 1985, pp. 1251-1255.
"Response of Feline Leukemia Virus-induced Nonregenerative Anemia to Oral Administration of an Interferon-containing Preparation", Feline Practice, vol. 12, No. 3, May-Jun. 1982, pp. 6-15, Tompkins, M. B. and Cummins, J. M.
"Interferon Enters The Fray", Farm Journal, Oct. 1985, pp. 12-13, Miller, B.
"Interferon as an Adjuvant for Hepatitis B Vaccination in Non- and Low-Responder Populations", Grob, P. J. et al., Eur. J. Clin. Microbiol., Jun. 1984, vol. 3, No. 3, pp. 195-198.
"Protection of Calves Against Rhinovirus Infection by Nasal Secretion Interferon Induced by Infectious Bovine Rhinotracheitis Virus", American Journal of Veterinary Research, Cummins, J. M. and Rosenquist, B. D., Feb. 1980, vol. 41, No. 2, pp. 161-165.
"Bovine Respiratory Disease-A Symposium", R. W. Loan, ed., Texas A&M University Press, College Station, TX, 1984, pp. 484-485.
"Activity Of Exogenous Interferon In The Human Nasal Mucosa", Texas Reports on Biology and Medicine, vol. 35, 1977, Greenberg, S. B., Harmon, M. W. and Johnson, P. E., pp. 491-496.
"Inhibition of Respiratory Virus Infection by Locally Applied Interferon", Merigan, T. C., Hall, T. S., Reed, S. E., and Tyrrell, D. A., The Lancet, Mar. 17, 1973, pp. 563-567.
"Trials of Interferon in Respiratory Infections of Man", Tyrrell, D. A. J., Texas Reports on Biology and Medicine, vol. 35, 1977, pp. 486-490.
"Bacteria-Derived Human Leukocyte Interferons After in Vitro Humoral and Cellular Immune Responses", Cellular Immunology, 82, 1983, pp. 269-281, by Shalaby, M. R. and Weck, P. K.
"Clinical and Laboratory Investigations on Man: Systemic Administration of Potent Interferon to Man", J. Natl. Cancer Inst., 51: 733-742, 1973, by Strander, H., Cantell, K., Carlstrom, G. and Jakobsson, P. A.
"Application of Human Leukocyte Interferon in Severe Cases of Virus B Hepatitis", Vlatkovic, R., et al., Proc. Symposium on Interferon 1979, Yugoslav Academy of Sciences and Arts, Zagreb, pp. 173-183.
"Effect of Interferon on Vaccination in Volunteers", The Lancet, Apr. 28, 1962, pp. 873-875 (Report to Medical Research Council from the Scientific Committee on Interferon).
"Induction of Ocular Resistance to Vaccinia Virus by Typhoid Vaccine: Role of Interferon", Oh, J. O. and Yoneda, C., The Journal of Immunology, vol. 102, No. 1, 1969, pp. 145-154.
"Clinical Trials with Exogenous Interferon: Summary of a Meeting", The Journal of Infectious Diseases, vol. 139, No. 1, Jan. 1979, pp. 109-123.
"Some Results and Prospects in the Study of Endogenous and Exogenous Interferon", The Interferson, An International Symposium, Soloviev, V. D., Geo. Rita, ed., Academic Press, 1968, pp. 233-243.
"Influenza and Interferon Research in the Soviet Union-Jan. 1973", The Journal of Infectious Diseases, vol. 128, No. 2, Aug. 1973, pp. 261-264.
"The Results of Controlled Observations on the Prophylaxis of Influenza with Interferon", Solov'ev, V. D., World Health Organization, 1949, 41, 683-688.
"Children's Respiratory Viral Diseases Treated With Interferon Aerosol", Jia-xiong, D. et al., Chinese Medical Journal, 100(2): 162-166, 1987.
Essential Clinical Virology, R. G. Sommerville, Blackwell Scientific Publications, pp. 154-157.
"Comparative Intranasal Pharmacokinetics of Interferon Using Two Spray Systems", Davies, H. W. et al., J. Interferon Research, 1983, pp. 443-449.
"The Common Cold Control?", Couch, R. B., The Journal of Infectious Diseases, vol. 150, No. 2, Aug. 1984, pp. 167-173.
Principles and Practice of Infectious Diseases, 2nd. ed., Mandell, G. L., Douglas, R. G. Jr., Bennett, J. E. eds., A Wiley Medical publication, pp. 85-96, 863, 968.
Antiviral Agents and Viral Diseases of Man, edited by G. J. Galasso, T. C. Merigan, R. A. Buchanan, Raven Press, New York, 1979, pp. 407-408, 430-431.
Antiviral Agents and Viral Diseases of Man, edited by G. J. Galasso, T. C. Merigan, R. a. Buchanan, Raven Press, New York, 1984, pp. 145-178, 344-345.
"Interferon Perspective", Information on Interferon provided in 1981 by the International Preventative Medicine Foundation, Melbourne FL, Ronald Jones, Vice President.
American Interhealth, Melbourne Beach, Florida, Production Information.
Biovet International, Inc., Canine and Feline Interferons, 1981 Product Description and Label.
"Agriferon.RTM.-C", Immuno Modulators Laboratories, Inc., Stafford, Texas, Lymphokine Preparation for Prophylactic Treatment of Infectious Bovine Rhinotracheitis Virus Associated with Shipping Fever-for Cattle Use in Texas Only, product brochure.
"Agriferon.RTM.-C", A bold new approach to managing shipping fever in cattle, Immuno Modulators Laboratories, Inc., Stafford, Texas, product advertisement.
"Equiferon", a totally new approach to viral respiratory infection in horses, Immuno Modulator Laboratories, Inc., Stafford, Texas, 1985, product advertisement.
"Pet Interferon Alpha", Amarillo Cell Culture Company, Inc., Amarillo, Texas, Lymphokine Preparation For Treatment of Feline Leukemia Virus and Canine Parvovirus Diseases, product brochure.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Low dosage of interferon to enhance vaccine efficiency does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Low dosage of interferon to enhance vaccine efficiency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low dosage of interferon to enhance vaccine efficiency will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-665935

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.